Who Paid My Doc
Penumbra System
Device Neurointervention
PDI 00814548019758
General payments
$3,335,484
Research payments
$1,499,402
Through program year 2025, $3,335,484 in general payments and $1,499,402 in research payments were reported against Penumbra System (Neurointervention).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $731,275 | 4,946 |
| 2024 | General | $1,015,232 | 4,488 |
| 2024 | Research | $4,550 | 1 |
| 2023 | General | $694,108 | 2,963 |
| 2023 | Research | $79,364 | 39 |
| 2022 | General | $681,877 | 2,289 |
| 2022 | Research | $659,033 | 403 |
| 2021 | General | $212,991 | 1,262 |
| 2021 | Research | $756,455 | 731 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 57 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
15,948 general · 1,174 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.